ProfileGDS4718 / 228488_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 65% 61% 68% 65% 58% 78% 77% 65% 62% 59% 56% 52% 67% 77% 74% 58% 65% 70% 79% 73% 62% 63% 68% 60% 57% 76% 59% 68% 72% 82% 70% 74% 61% 54% 63% 78% 59% 59% 61% 68% 67% 71% 74% 70% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.4978665
GSM549102patient 115, normal, homogenized [OPG study]6.2197961
GSM549104patient 119, normal, homogenized [OPG study]6.7435468
GSM549108patient 138, normal, homogenized [OPG study]6.4596165
GSM549119patient 077, normal, homogenized [OPG study]6.0202458
GSM549133patient 032, cancer, homogenized [OPG study]7.7140278
GSM549139patient 042, cancer, homogenized [OPG study]7.5284177
GSM549099patient 107, normal, homogenized [OPG study]6.453365
GSM549109patient 139, normal, homogenized [OPG study]6.2385562
GSM549110patient 046, normal, homogenized [OPG study]6.0710359
GSM549114patient 063, normal, homogenized [OPG study]5.8133456
GSM549122patient 082, normal, homogenized [OPG study]5.6641352
GSM549134patient 033, cancer, homogenized [OPG study]6.6636167
GSM549136patient 036, cancer, homogenized [OPG study]7.6613677
GSM549140patient 044, cancer, homogenized [OPG study]7.3273174
GSM549111patient 047, normal, homogenized [OPG study]5.9830858
GSM549113patient 057, normal, homogenized [OPG study]6.4503665
GSM549132patient 031, cancer, homogenized [OPG study]6.8711370
GSM549137patient 038, cancer, homogenized [OPG study]7.7786879
GSM549142patient 047, cancer, homogenized [OPG study]7.0513873
GSM549100patient 110, normal, homogenized [OPG study]6.2683462
GSM549107patient 135, normal, homogenized [OPG study]6.3508363
GSM549115patient 068, normal, homogenized [OPG study]6.7095868
GSM549116patient 072, normal, homogenized [OPG study]6.1046460
GSM549120patient 078, normal, homogenized [OPG study]5.9546357
GSM549131patient 030, cancer, homogenized [OPG study]7.5831576
GSM549118patient 074, normal, homogenized [OPG study]6.0548559
GSM549129patient 027, cancer, homogenized [OPG study]6.7483268
GSM549123patient 088, normal, homogenized [OPG study]7.0214772
GSM549124patient 006, cancer, homogenized [OPG study]7.9657682
GSM549126patient 015, cancer, homogenized [OPG study]6.8383770
GSM549128patient 025, cancer, homogenized [OPG study]7.3336774
GSM549103patient 117, normal, homogenized [OPG study]6.1777561
GSM549117patient 073, normal, homogenized [OPG study]5.6843554
GSM549138patient 041, cancer, homogenized [OPG study]6.3575463
GSM549141patient 045, cancer, homogenized [OPG study]7.7300978
GSM549130patient 028, cancer, homogenized [OPG study]6.0862159
GSM549101patient 111, normal, homogenized [OPG study]6.0815559
GSM549105patient 128, normal, homogenized [OPG study]6.1784861
GSM549106patient 134, normal, homogenized [OPG study]6.7387168
GSM549112patient 048, normal, homogenized [OPG study]6.6399467
GSM549125patient 011, cancer, homogenized [OPG study]6.9234671
GSM549127patient 024, cancer, homogenized [OPG study]7.3102774
GSM549135patient 035, cancer, homogenized [OPG study]6.9568370